Keyphrases
Romiplostim
100%
Supportive Care
100%
Ewing Sarcoma
100%
Chemotherapy-induced Thrombocytopenia
100%
Chemotherapy
42%
Univariate Analysis
28%
Chemotherapy Cycles
28%
Risk Factors
14%
Headache
14%
Platelets
14%
Ifosfamide
14%
Etoposide
14%
Identify Risk
14%
Consolidation Therapy
14%
Thrombopoietin Receptor Agonists (TPO-RAs)
14%
Starting Dose
14%
Adverse Events
14%
Pearson Correlation Coefficient
14%
Platelet Count
14%
Fisher's Exact Test
14%
Myelosuppression
14%
Microliter
14%
Concurrent Use
14%
Treatment Intensity
14%
Dose-dense
14%
Medicine and Dentistry
Romiplostim
100%
Ewing Sarcoma
100%
Supportive Care
100%
Thrombocytopenia
100%
Platelet
28%
Univariate Analysis
28%
Adverse Event
14%
Fisher Exact Test
14%
Bone Marrow Suppression
14%
Headache
14%
Dose Densification
14%
Ifosfamide
14%
Etoposide
14%
Thrombopoietin Receptor
14%
Nursing and Health Professions
Ewing Sarcoma
100%
Thrombocytopenia
100%
Romiplostim
100%
Univariate Analysis
28%
Correlation Coefficient
14%
Platelet Count
14%
Adverse Event
14%
Headache
14%
Fisher Exact Test
14%
Ifosfamide
14%
Etoposide
14%
Bone Marrow Suppression
14%
Efficacy
14%
Dose Densification
14%
Thrombopoietin Receptor
14%
Pharmacology, Toxicology and Pharmaceutical Science
Chemotherapy
100%
Romiplostim
100%
Ewing Sarcoma
100%
Thrombocytopenia
100%
Etoposide
8%
Ifosfamide
8%
Receptor Agonist
8%
Headache
8%
Adverse Event
8%
Bone Marrow Suppression
8%
Thrombopoietin Receptor
8%
Agricultural and Biological Sciences
Risk Factor
100%
Agonist
100%
Headache
100%
Thrombopoietin Receptor
100%